MSB 10.4% $1.49 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-39

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,224 Posts.
    lightbulb Created with Sketch. 44
    Well because there is a concrete date which will finalise a final step to approval, of course the share is worth more today as this uncertainly has been mitigated
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.49
Change
0.140(10.4%)
Mkt cap ! $1.701B
Open High Low Value Volume
$1.37 $1.54 $1.37 $23.10M 15.82M

Buyers (Bids)

No. Vol. Price($)
3 24758 $1.49
 

Sellers (Offers)

Price($) Vol. No.
$1.49 73626 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.